Our observations showed that a decreasing trend of POLβ levels was demonstrated starting from TDLUs, pure DCIS series, DCIS component coexisting with invasive disease and invasive component which showed the lowest level of POLβ protein in the study cohort. The gene discussed is POLB; the disease is ductal breast carcinoma in situ.